# Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): <scp>D</scp> ata from randomized controlled trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-issues-with-glucagon-like-peptide-1-receptor-agonists-pancreatitis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Matteo Monami,Besmir Nreu,Alessia Scatena,Barbara Cresci,Francesco Andreozzi,Giorgio Sesti,Edoardo Mannucci |
| Citations | 232 |
| DOI | 10.1111/dom.12926 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2592954074 |
| PMID | 28244632 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Matteo Monami](https://scholariq.org/researchers/matteo-monami/)
- [Edoardo Mannucci](https://scholariq.org/researchers/edoardo-mannucci/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatitis Pathology and Treatment](https://scholariq.org/topics/pancreatitis-pathology-and-treatment/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.